Ophthalmology Doctors in Prescott, AZ Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

Robert Mark Rummel, MD, PHD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1022 Willow Creek Rd, Suite 200, Prescott, AZ 86301 Phone: 928-445-1341    Fax: 928-778-3993

Dr. Robert Walter Jensen, MD JD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 820 Ainsworth Dr Ste A, Prescott, AZ 86301 Phone: 928-778-0827    Fax: 928-778-5622

Dr. James Brayshaw Arthur, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3769 Crossings Drive, Prescott, AZ 86305 Phone: 928-445-9200    Fax: 928-771-8107

Robert Willard Preston, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1022 Willow Creek Rd, Suite 200, Prescott, AZ 86301 Phone: 928-445-1341    Fax: 928-778-3993

Kyle Piwonka, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3192 Willow Creek Rd, Prescott, AZ 86301 Phone: 928-445-1234    Fax: 928-771-8107

John Harold Rummel, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1022 Willow Creek Rd, Suite 200, Prescott, AZ 86301 Phone: 928-445-1341    Fax: 928-778-3993

Dr. Steven Worthen Mortenson, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3192 Willow Creek Rd, Prescott, AZ 86301 Phone: 928-778-3950

Dr. Scott Patrick Markham, D.O. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1680 Willow Creek Rd, Prescott, AZ 86301 Phone: 928-778-3950    Fax: 928-778-3999

News Archive

Onyx announces data from regorafenib Phase 3 trial on GIST

Onyx Pharmaceuticals today announced data from the Phase 3 GRID (GIST – Regorafenib In Progressive Disease) trial evaluating the investigational drug regorafenib, a Bayer compound, in patients with metastatic and/or unresectable gastrointestinal stromal tumors (GIST) whose disease had progressed despite prior treatment with imatinib and sunitinib.

Latinos living in the United States have high rates of eye disease and visual impairment

Researchers found that Latinos had high rates of diabetic retinopathy, an eye complication of diabetes; and open-angle glaucoma, a disease that damages the optic nerve.

LLS's School & Youth Programs raise $1M to help fight against childhood cancer

Participants in The Leukemia & Lymphoma Society's Greater Los Angeles Chapter School & Youth(SM) Programs raised an unprecedented $1 million this spring, in a campaign that gives kids a chance to help in the fight against blood cancers.

Merck signs in vitro fertilization deal with Genea Biomedx

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, today announced the global collaboration agreement with the fertility technologies expert Genea Biomedx, an Australian company, dedicated to advancing fertility science and helping couples create families. With this partnership, Merck Serono, the biopharmaceutical business of Merck, and global market leader in drugs for Assisted Reproductive Treatment (ART), receives global marketing and commercialization rights to Genea Biomedx's product portfolio.

Read more Medical News

› Verified 1 days ago